
Sign up to save your podcasts
Or
This week on The Tox Lab, we’re diving into novel nitazene metabolites in post-mortem toxicology.
We discuss findings from our own paper identifying metabolites of protonitazene in post-mortem casework, and highlight the variability in metabolites identified and what this might mean for identifying nitazene exposure. We also examine a post-mortem case report on 5-amino and 5-acetamido metonitazene which discusses if their presence may be the result of metabolism or instability within the sample.
Join us as we unpack the complexity of interpreting nitazenes in the post-mortem setting.
Hope you enjoy!
Links to the papers we discussed:
https://academic.oup.com/jat/advance-article-abstract/doi/10.1093/jat/bkaf042/8128869
https://academic.oup.com/jat/article-abstract/48/9/691/7747396?login=false
https://academic.oup.com/jat/advance-article-abstract/doi/10.1093/jat/bkaf070/8203075?redirectedFrom=fulltext
Disclaimer: All opinions are our own.
Find us on instagram: @the_tox_lab
Email us here: [email protected]
This week on The Tox Lab, we’re diving into novel nitazene metabolites in post-mortem toxicology.
We discuss findings from our own paper identifying metabolites of protonitazene in post-mortem casework, and highlight the variability in metabolites identified and what this might mean for identifying nitazene exposure. We also examine a post-mortem case report on 5-amino and 5-acetamido metonitazene which discusses if their presence may be the result of metabolism or instability within the sample.
Join us as we unpack the complexity of interpreting nitazenes in the post-mortem setting.
Hope you enjoy!
Links to the papers we discussed:
https://academic.oup.com/jat/advance-article-abstract/doi/10.1093/jat/bkaf042/8128869
https://academic.oup.com/jat/article-abstract/48/9/691/7747396?login=false
https://academic.oup.com/jat/advance-article-abstract/doi/10.1093/jat/bkaf070/8203075?redirectedFrom=fulltext
Disclaimer: All opinions are our own.
Find us on instagram: @the_tox_lab
Email us here: [email protected]